Equities research analysts at CJS Securities began coverage on shares of BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) in a research report issued on Thursday, Marketbeat reports. The brokerage set an "outperform" rating and a $27.00 price target on the stock. CJS Securities' price objective suggests a potential upside of 50.50% from the company's previous close.
A number of other brokerages have also recently weighed in on BTSG. Bank of America lifted their price objective on shares of BrightSpring Health Services from $19.00 to $21.00 and gave the company a "buy" rating in a research note on Wednesday. Wells Fargo & Company upped their price target on shares of BrightSpring Health Services from $17.00 to $21.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 27th. Mizuho increased their price objective on shares of BrightSpring Health Services from $17.00 to $20.00 and gave the company an "outperform" rating in a report on Monday, November 4th. BTIG Research boosted their target price on BrightSpring Health Services from $15.00 to $20.00 and gave the stock a "buy" rating in a report on Thursday, October 3rd. Finally, UBS Group increased their price target on BrightSpring Health Services from $16.00 to $20.00 and gave the company a "buy" rating in a research note on Wednesday, October 30th. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. According to MarketBeat, BrightSpring Health Services has an average rating of "Moderate Buy" and a consensus target price of $18.50.
View Our Latest Stock Analysis on BTSG
BrightSpring Health Services Stock Performance
Shares of BTSG stock traded down $0.43 during trading hours on Thursday, reaching $17.94. The stock had a trading volume of 878,060 shares, compared to its average volume of 1,448,067. The firm has a market capitalization of $3.12 billion and a PE ratio of -69.00. The firm has a 50-day simple moving average of $17.41 and a 200-day simple moving average of $14.00. BrightSpring Health Services has a twelve month low of $7.85 and a twelve month high of $20.25. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last issued its quarterly earnings data on Friday, November 1st. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.07). BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The business had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.72 billion. The company's revenue was up 28.8% compared to the same quarter last year. As a group, equities analysts forecast that BrightSpring Health Services will post 0.59 earnings per share for the current year.
Hedge Funds Weigh In On BrightSpring Health Services
A number of institutional investors have recently bought and sold shares of the stock. nVerses Capital LLC acquired a new stake in BrightSpring Health Services during the 2nd quarter valued at $55,000. California State Teachers Retirement System bought a new position in shares of BrightSpring Health Services in the first quarter valued at about $59,000. Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in BrightSpring Health Services during the 2nd quarter worth about $126,000. Intech Investment Management LLC acquired a new position in BrightSpring Health Services during the 3rd quarter worth about $159,000. Finally, Arizona State Retirement System bought a new stake in BrightSpring Health Services during the 2nd quarter worth about $163,000.
BrightSpring Health Services Company Profile
(
Get Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Featured Stories
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.